Ryan Fukushima Sells 5,000 Shares of Tempus AI (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM) COO Ryan Fukushima sold 5,000 shares of the business’s stock in a transaction dated Monday, December 1st. The stock was sold at an average price of $75.72, for a total transaction of $378,600.00. Following the completion of the sale, the chief operating officer directly owned 153,808 shares of the company’s stock, valued at $11,646,341.76. The trade was a 3.15% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Ryan Fukushima also recently made the following trade(s):

• On Tuesday, November 18th, Ryan Fukushima sold 10,099 shares of Tempus AI stock. The stock was sold at an average price of $65.54, for a total transaction of $661,888.46.
• On Monday, November 3rd, Ryan Fukushima sold 5,000 shares of Tempus AI stock. The stock was sold at an average price of $89.03, for a total value of $445,150.00.
• On Monday, October 6th, Ryan Fukushima sold 5,000 shares of Tempus AI stock. The shares were sold at an average price of $92.32, for a total value of $461,600.00.

Tempus AI Trading Up 1.9%

NASDAQ:TEM opened at $76.33 on Friday. The company has a market cap of $13.58 billion, a PE ratio of -64.14 and a beta of 4.99. The business’s 50 day moving average is $82.12 and its two-hundred day moving average is $72.84. The company has a quick ratio of 3.12, a current ratio of 3.28 and a debt-to-equity ratio of 2.45. Tempus AI, Inc. has a 52 week low of $31.36 and a 52 week high of $104.32.

Tempus AI (NASDAQ:TEM) last posted its quarterly earnings results on Tuesday, November 4th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.16) by $0.05. Tempus AI had a negative return on equity of 73.21% and a negative net margin of 18.45%.The business had revenue of $334.21 million for the quarter, compared to analyst estimates of $328.89 million. During the same period in the prior year, the company posted ($0.46) EPS. The business’s revenue was up 84.7% compared to the same quarter last year. On average, analysts predict that Tempus AI, Inc. will post -6.15 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on TEM shares. Needham & Company LLC lifted their price target on shares of Tempus AI from $70.00 to $100.00 and gave the company a “buy” rating in a report on Wednesday, November 5th. Cowen downgraded Tempus AI from a “buy” rating to a “hold” rating in a research note on Tuesday, October 21st. HC Wainwright dropped their price target on Tempus AI from $98.00 to $89.00 and set a “buy” rating on the stock in a research report on Friday, November 7th. Piper Sandler reduced their price objective on Tempus AI from $105.00 to $80.00 and set a “neutral” rating for the company in a research report on Tuesday, November 11th. Finally, Morgan Stanley upped their price objective on Tempus AI from $80.00 to $85.00 and gave the stock an “overweight” rating in a research note on Monday. Seven investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Tempus AI presently has an average rating of “Hold” and an average price target of $81.17.

Hedge Funds Weigh In On Tempus AI

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Allworth Financial LP increased its position in Tempus AI by 73.9% in the 3rd quarter. Allworth Financial LP now owns 798 shares of the company’s stock valued at $64,000 after acquiring an additional 339 shares during the period. IFP Advisors Inc grew its stake in shares of Tempus AI by 140.1% in the third quarter. IFP Advisors Inc now owns 4,274 shares of the company’s stock worth $345,000 after purchasing an additional 2,494 shares in the last quarter. Swiss Life Asset Management Ltd acquired a new position in shares of Tempus AI during the third quarter valued at $349,000. EMC Capital Management bought a new stake in shares of Tempus AI during the third quarter valued at about $297,000. Finally, Sunbelt Securities Inc. bought a new stake in shares of Tempus AI during the third quarter valued at about $52,000. 24.22% of the stock is currently owned by institutional investors and hedge funds.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.